Found: 7
Select item for more details and to access through your institution.
Chemosensitized radiosurgery for recurrent brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 265, doi. 10.1007/s11060-012-0965-6
- By:
- Publication type:
- Article
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221105024
- By:
- Publication type:
- Article
Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 3191, doi. 10.2147/CMAR.S376510
- By:
- Publication type:
- Article
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O<sup>6</sup>-methylguanine DNA methyltransferase expression.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 5, p. 664, doi. 10.1111/bjh.13094
- By:
- Publication type:
- Article
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20061-6
- By:
- Publication type:
- Article
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20061-6
- By:
- Publication type:
- Article